Skip to main content
Clinical Trials/NCT03974438
NCT03974438CompletedNot Applicable

Acupuncture (Dry-needling) as Treatment of Post-herpetic Neuralgia: A Double-blinded Randomized Clinical Trial.

Odense University Hospital1 site in 1 country40 target enrollmentStarted: September 19, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Dermal pain [LEVEL OF PAIN]

Study Overview

Brief Summary

The aim of this study is to perform the first RCT investigating the possible effect of superficial dry-needling (SDN) - a special kind of acupuncture used for PHN. The participants will be divided into two groups. Group A, the intervention group will receive SDN in the area of pain. Group B, the control group will receive a sham procedure.

Detailed Description

The aim of this study is to investigate the possible effect of SDN on PHN. The study population consists of patients with chronic pain after herpes zoster.

The study is a controlled double-blinded randomized study. The participants will be divided into two groups, group A, the intervention group, will receive SDN in the area of pain. Group B, the control group will receive a sham procedure. The procedure will take place at the out-patient clinic at Odense University Hospital. The plan is to include 40 patients (20 in each group).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Masking Description

Participants will not be aware of the treatment given. The randomization will take place right before the procedure begins. The treatment will be given to the skin covering the spine and the patients will be placed in the supine position. They will therefore not know whether or not they are receiving the actual acupuncture or the sham procedure.

The investigator will not be present at the procedures and will not have access to patients records and data until after the trial is complete.

The outcomes are measured using validated questionnaires. They will be assessed by the investigator at the time of project completion.

Eligibility Criteria

Ages
55 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age between 50-75 years.
  • •Pain in the dermatomal area of the previous outbreak of HZ.
  • •Pain located to a dermatome originating from the thoracic or lumbar spine.
  • •At least six months since the outbreak.
  • •Understands the purpose of the study and is able to give consent.

Exclusion Criteria

  • •A psychiatric illness affecting participation in the study.
  • •Active cancer
  • •Pregnancy

Arms & Interventions

Intervention - Acupunture (SDN)

Experimental

Patients allocated to the intervention arm will receive SDN to the area of skin over the spine on the level of the specific dermatome involved in their chronic pain.

Intervention: Superficial dry needling / Acupunture (Procedure)

Control - Sham acupunture

Sham Comparator

Patients allocated to the control arm will receive sham-SDN to the area of skin over the spine on the level of the specific dermatome involved in their chronic pain. The sham procedure consists of a blunted needle, that does not penetrate the skin.

Intervention: Superficial dry needling / Acupunture (Procedure)

Outcomes

Primary Outcomes

Dermal pain [LEVEL OF PAIN]

Time Frame: 1 month

Questionnaire. Visual Analogue Scale (VAS). Patients will be asked to report on their average and maximum level of pain on a scale from 0-10.

Secondary Outcomes

  • Neuropathic pain [LEVEL OF PAIN](1 month)
  • Quality of life [QUALITY OF LIFE/ SATISFACTION](1 month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Martin Sollie

Principal investigator, M.D, Dept. of Plastic and Reconstructive Surgery Affiliation: Odense University Hospital Collaborators:

Odense University Hospital

Study Sites (1)

Loading locations...

Similar Trials